Video Experimental Relacionado
Updated: May 19, 2026
11:11
Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
Published on: April 25, 2018
Los ARN monocatenarios utilizan el ARNi para inhibir potentemente y alelo-selectivamente la expresión de la
Dongbo Yu1, Hannah Pendergraff, Jing Liu
1Departments of Pharmacology and Biochemistry, UT Southwestern Medical Center, 6001 Forest Park Road, Dallas, TX 75390-9041, USA.
Cell
|September 4, 2012
Resumen
Los nuevos siRNAs de una sola cadena (ss-siRNAs) ofrecen un enfoque potente y alelo-selectivo para silenciar la proteína huntingtina mutante (HTT), abordando la causa raíz de la enfermedad de Huntington (HD). Esta terapia basada en ARNi muestra una promesa para el desarrollo clínico.
Área de la Ciencia:
- La neurociencia es la neurociencia.
- Biología Molecular Biología Molecular
- Genética La genética.
Sus antecedentes:
- La enfermedad de Huntington (HD) es un trastorno neurodegenerativo fatal causado por la proteína huntingtina mutante (HTT).
- Los tratamientos actuales para la EH son limitados, lo que destaca la necesidad de terapias dirigidas al origen genético de la enfermedad.
- El desarrollo de terapias efectivas basadas en ácido nucleico para el silenciamiento de genes presenta desafíos significativos.
Objetivo del estudio:
- Desarrollar un nuevo enfoque de silenciamiento de genes para la enfermedad de Huntington mediante la combinación de la simplicidad del oligonucleótido antisentido con la eficiencia de la interferencia de ARN (RNAi).
- Investigar el potencial de los siRNAs de una sola cadena (ss-siRNAs) como inhibidores potentes y alelo-selectivos de la expresión mutante de HTT.
- Para evaluar la eficacia in vivo de ss-siRNAs en un modelo de ratón de la enfermedad de Huntington.
Principales métodos:
- Diseño y síntesis de siRNAs de una sola cadena modificados químicamente (ss-siRNAs) con bases estratégicas no coincidentes.
- Evaluación in vitro de la potencia del ss-siRNA y la selectividad de alelos en células derivadas de pacientes.
- Validación funcional de ss-siRNAs a través de la vía de interferencia de ARN (RNAi), incluida la dependencia de proteínas argonautas.
- Entrega in vivo de ss-siRNAs a través de infusión intraventricular en un modelo de ratón de la enfermedad de Huntington.
Principales resultados:
- ss-siRNAs demostró una potente inhibición de la expresión mutante HTT, excediendo el ARN no modificado en más de 100 veces.
- ss-siRNAs exhibieron una alta selectividad de alelos, discriminando entre alelos HTT de tipo mutante y salvaje por más de 30 veces.
- La colocación desajustada de bases en ss-siRNAs fue crucial para el reconocimiento de micro-ARN y la discriminación de alelos.
- La infusión intraventricular de ss-siRNAs condujo al silenciamiento selectivo del alelo HTT mutante en todo el cerebro in vivo.
Conclusiones:
- Los ss-siRNA modificados químicamente son efectivos a través de la vía del RNAi para el silenciamiento de genes potentes y alelo-selectivos.
- ss-siRNAs representan una estrategia terapéutica prometedora para la enfermedad de Huntington, dirigida a la causa raíz del trastorno.
- Estos hallazgos proporcionan una base para el desarrollo clínico de ss-siRNAs como tratamiento para la enfermedad de Huntington.
Más Videos Relacionados
Videos de Conceptos Relacionados
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:20Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
01:23Types of RNA
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...